Ahmed R.L., Prizment A., Lazovich D., Schmitz K.H., Folsom A.R. (2008) Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J. Clin. Oncol., 26(35): 5689. DOI: 10.1200/JCO.2008.16.4731
Babasaheb S.S., Rajesh K.K., Yeshwant K.S., Patil S. (2021) Analysis of spinal dysfunction in breast cancer survivors with lymphedema. APJCP, 22(6): 1869. DOI: 10.31557/APJCP.2021.22.6.1869
Bakar Y., Tuğral A., Özdemir Ö., Duygu E., Üyetürk Ü. (2017) Translation and validation of the Turkish version of lymphedema quality of life tool (LYMQOL) in patients with breast cancer related lymphedema. Eur. J. Breast Health, 13(3): 123. DOI: 10.5152/ejbh.2017.3522
Baran E., Özçakar L., Özgül S., Aksoy S., Akbayrak T. (2021) Upper limb sensory evaluations and ultrasonographic skin measurements in breast cancer– related lymphedema receiving complex decongestive physiotherapy. Support Care Cancer, 29: 6545-6553. DOI: 10.1007/s00520-021-06235-4.
Basoglu C., Sindel D., Corum M., Oral A. (2021) Comparison of complete decongestive therapy and kinesiology taping for unilateral upper limb breast cancer-related lymphedema: A randomized controlled trial. Lymphology, 54(1): 41-51.
Belmonte R., Messaggi-Sartor M., Ferrer M., Pont A., Escalada F. (2018) Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB. Support Care Cancer, 26: 3277-3287. DOI: 10.1007/s00520-018-4186-1
Carlson J.A. (2014) Lymphedema and subclinical lymphostasis (microlymphedema) facilitate cutaneous infection, inflammatory dermatoses, and neoplasia: a locus minoris resistentiae. Clin. Dermato, 32(5): 599-615. DOI: 10.1016/j.clindermatol.2014.04.007
Çolak H., Kızılırmak A., Karadağ S. (2022) The functional use of the arms of patients with breast cancer after surgical treatment and their behaviors to prevent lymph-edema. PREPRINT (Version 1) available at Research Square. DOI: 10.21203/rs.3.rs-1574274/v1
Dawes D.J., Meterissian S., Goldberg M., Mayo N.E. (2008) Impact of lymphoedema on arm function and health-related quality of life in women following breast cancer surgery. J. Rehabil. Med., 40(8): 651.
Devoogdt N., Van Kampen M., Geraerts I., Coremans T., Christiaens M.R. (2011) Lymphoedema Functioning, Disability and Health questionnaire (Lymph-ICF): reliability and validity. Phys. Ther., 91(6): 944-957. DOI: 10.2522/ptj.20100087
De Vrieze T., Gebruers N., Nevelsteen I., Tjalma W.A., Thomis S., De Groe A., Devoogdt N. (2020) Physical activity level and age contribute to functioning problems in patients with breast cancer-related lymphedema: a multicentre cross-sectional study. Support Care Cancer, 28: 5717-5731. DOI: 10.1007/s00520-020-05375-3
DiSipio T., Rye S., Newman B., Hayes S. (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol., 14(6): 500-515. DOI: 10.1016/S1470-2045(13)70076-7
Donepudi M.S., Kondapalli K., Amos S.J., Venkanteshan P. (2014) Breast cancer statistics and markers. J. Cancer Res. Ther., 10(3): 506-511. DOI: 10.4103/0973-1482.137927
Düger T., Yakut E., Öksüz Ç., Yörükan S., Bilgütay B.S., Ayhan Ç., Güler Ç. (2006) Turkish Validity and Reliability of the Disabilities of the arm, shoulder and hand-DASH Questionnaire, Physiother., Rehabil., 17(3): 99-107.
Ferlay J., Soerjomataram I., Dikshit R., Eser S., Math-ers C., Rebelo M., Bray F. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136(5): E359-E386. DOI: 10.1002/ijc.29210
Geller B.M., Vacek P.M., O’Brien P., Secker-Walker R.H. (2003) Factors associated with arm swelling after breast cancer surgery. J. Womens Health (Larchmt), 12(9): 921-930. DOI: 10.1089/154099903770948159
Haddad C.A.S., Saad M., Perez M.D.C.J., Miranda Júnior F. (2013) Assessment of posture and joint movements of the upper limbs of patients after mastectomy and lymphadenectomy. Einstein (Sao Paulo), 11: 426-434. DOI: 10.1590/S1679-45082013000400004
Hudak P.L., Amadio P.C., Bombardier C., Beaton D., Cole D., Davis A., Wright J. (1996) Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder, and head). Am. J. Ind. Med, 29(6): 602-608. DOI: 10.1002/(SICI)1097-0274-(199606)29:6<;602::AID-AJIM4>3.0.CO;2-L
Feuk G.I.B. (2000) Morbidity from axillary treatment in breast cancer: a follow-up study in a district hospital. Acta Oncologica, 39(3): 335-336. DOI: 10.1080/028418600750013104
Jamshidi F., Farzad M., MacDermid J.C., Varahra A., Hosseini S.A., Asgarabad M.H. (2022) Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review. Breast Cancer, 29(3): 377-393. DOI: 10.1007/s12282-022-01340-6
Kayali A. Validity and reliability study of the Turkish version of ULL-27 quality of life questionnaire developed specifically for upper extremity lymphedema patients (Master’s thesis, Institute of Health Sciences).
Keeley V., Crooks S., Locke J., Veigas D., Riches K., Hilliam R. (2010) A quality of life measure for limb lymphoedema (LYMQOL). J. Lymphoedema, 5(1): 26-37.
Kostanoglu A., Hosbay Z., Tarakci E. (2016) Lymphoedema functioning, disability and health questionnaire Turkish version: translation, cross-cultural adaptation and validation. J. Phys. Ther. Sci., 28(6): 1728-1732. DOI: 10.1589/jpts.28.1728
Launois R., Megnigbeto A.C., Pocquet K., Alliot F., Campisi C., Witte M.H. (2002) A specific quality of life scale in upper limb lymphedema: the ULL-27 questionnaire. Lymphology, 35(1-760): 181-7.
Leray H., Malloizel-Delaunay J., Lusque A., Chantalat E., Bouglon L., Chollet C., Vaysse C. (2020) Body mass index as a major risk factor for severe breast cancer-related lymphedema. Lymphat. Res. Biol., 18(6): 510-516. DOI: 10.1089/lrb.2019.0009
Levangie P.K., Drouin J. (2009) Magnitude of late effects of breast cancer treatments on shoulder function: a systematic review. Breast Cancer Res. Treat., 116: 1-15. DOI: 10.1007/s10549-008-0246-4
Lim P., Li H., Neoh D., Ng S.K.H. (2022) Health-related Quality of Life Measurement Tools for Lymphedema: A Review of the Literature. Plast. Reconstr. Surg., 10(4): DOI: 10.1097/GOX.0000000000004276
McDuff S.G., Mina A.I., Brunelle C.L., Salama L., Warren L.E., Abouegylah M., Taghia A.G. (2019) Timing of lymphedema after treatment for breast cancer: when are patients most at risk? J. Radiat. Oncol., 103(1): 62-70. DOI: 10.1016/j.ijrobp.2018.08.036
Norman S.A., Localio A.R., Kallan M.J., Weber A.L., Simoes Torpey H.A., Potashnik S. L., Solin L. J. (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol. Biomarkers Prev., 19(11): 2734-2746. DOI: 10.1158/1055-9965.EPI-09-1245
Obeng-Gyasi S., Coles C.E., Jones J., Sacks R., Light-owlers S., Bliss J.M., Kalinsky K. (2021) When the world throws you a curve ball: lessons learned in breast cancer management. J. Oncol. Pract., 41: e79-e89.
Park J.E., Jang H. J., Seo K.S. (2012) Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann. Rehabil. Med., 36(2): 240-247. DOI: 10.5535/arm.2012.36.2.240
Passik S.D., McDonald M.V. (1998) Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer, 83(S12B): 2817-2820. DOI: 10.1002/(SICI)1097-0142(19981215)83:12B+<;2817::AIDCNCR32>3.0.CO;2-2
Pezner R.D., Patterson M.P., Hill L.R., Lipsett J.A., Desai K.R., Vora N., Luk K.H. (1986) Arm lymphedema in patients treated conservatively for breast cancer: relationship to patient age and axillary node dissection technique. J. Radiat. Oncol., 12(12): 2079-2083. DOI: 10.1016/0360-3016(86)90005-2
Pusic A.L., Cemal Y., Albornoz C., Klassen A., Cano S., Sulimanoff I., Mehrara B. (2013) Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J. Cancer Surviv., 7: 83-92. DOI: 10.1007/s11764-012-0247-5
Rietman J.S., Dijkstra P.U., Hoekstra H.J., Eisma W.H., Szabo B.G., Groothoff J.W., Geertzen J.H. (2003) Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur. J. Surg. Oncol., 29(3): 229-238. DOI: 10.1053/ejso.2002.1403
Ridner S.H., Dietrich M.S., Stewart B.R., Armer J.M. (2011) Body mass index and breast cancer treatment- related lymphedema. Support Care Cancer, 19: 853-857. DOI: 10.1007/s00520-011-1089-9
Ridner S.H., Bonner C.M., Deng J., Sinclair V.G. (2012) Voices from the shadows: living with lymph-edema. Cancer nursing, 35(1): E18. DOI: 10.1097/NCC.0b013e31821404c0
Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin., 71(3): 209-249. DOI: 10.3322/caac.21660
Taghian N.R., Miller C.L., Jammallo L.S., O’Toole J., Skolny M.N. (2014) Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit. Rev. Oncol. Hematol., 92(3): 227-234. DOI: 10.1016/j. critrevonc.2014.06.004
Thompson B., Gaitatzis K., Janse de Jonge X., Blackwell R., Koelmeyer L.A. (2021) Manual lymphatic drainage treatment for lymphedema: a systematic review of the literature. J. Cancer. Surviv., 15: 244-258. DOI: 10.1007/s11764-020-00928-1
Quirion E. (2010) CE ARTICLE: Recognizing and treating upper extremity lymphedema in postmastectomy/lumpectomy patients: A guide for primary care providers. J. Am. Acad. Nurse Pract., 22(9): 450-459. DOI: 10.1111/j.1745-7599.2010.00542.x